Use of interleukin-2 (IL-2) receptor-specific agents to treat allograft rejection

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5916559
SERIAL NO

08761975

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of lysing unwanted, non-malignant cells in a mammal, the cells having on their surfaces a receptor for a growth factor, and the method including administering to the mammal a cell-lysing amount of a substance characterized in that it has specific affinity for the receptor of the growth factor and has the ability to effect the lysis of the cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE BETH ISRAEL HOSPITAL ASSOCIATIONMASSACHUSETTS 02215 MARLBOROUGH MASSACHUSETTS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Strom, Terry B Brookline, MA 49 706

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation